BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 25583385)

  • 21. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
    Delogu G; Vanini V; Cuzzi G; Chiacchio T; De Maio F; Battah B; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
    Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
    Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17 and IFN-γ production in peripheral blood following BCG vaccination and Mycobacterium tuberculosis infection in human.
    Li Q; Li J; Tian J; Zhu B; Zhang Y; Yang K; Ling Y; Hu Y
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):2029-36. PubMed ID: 23242733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders.
    Michelsen SW; Soborg B; Agger EM; Diaz LJ; Hoff ST; Koch A; Sorensen HCF; Andersen P; Wohlfahrt J; Melbye M
    Vaccine; 2016 Nov; 34(48):5975-5983. PubMed ID: 27997344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis.
    Parra M; Pickett T; Delogu G; Dheenadhayalan V; Debrie AS; Locht C; Brennan MJ
    Infect Immun; 2004 Dec; 72(12):6799-805. PubMed ID: 15557600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice.
    Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H
    Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine.
    Hu Z; Gu L; Li CL; Shu T; Lowrie DB; Fan XY
    Front Immunol; 2018; 9():1796. PubMed ID: 30123219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis.
    Saqib M; Khatri R; Singh B; Gupta A; Kumar A; Bhaskar S
    Tuberculosis (Edinb); 2016 Dec; 101():164-173. PubMed ID: 27865389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG.
    Villarreal DO; Walters J; Laddy DJ; Yan J; Weiner DB
    Hum Vaccin Immunother; 2014; 10(8):2188-98. PubMed ID: 25424922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
    Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
    Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children.
    Anuradha B; Rakh SS; Ishaq M; Murthy KJ; Valluri VL
    Pediatr Infect Dis J; 2008 Apr; 27(4):325-9. PubMed ID: 18379373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.
    Delogu G; Chiacchio T; Vanini V; Butera O; Cuzzi G; Bua A; Molicotti P; Zanetti S; Lauria FN; Grisetti S; Magnavita N; Fadda G; Girardi E; Goletti D
    PLoS One; 2011 Mar; 6(3):e18315. PubMed ID: 21479248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.